{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:17:13Z","timestamp":1763018233607,"version":"3.37.3"},"reference-count":57,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000},"content-version":"unspecified","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1127297"],"award-info":[{"award-number":["APP1127297"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Scabies is a significant contributor to global morbidity, affecting approximately 200\u2009million people at any time. Scabies is endemic in many resource-limited tropical settings. Bacterial skin infection (impetigo) frequently complicates scabies infestation in these settings. Community-wide ivermectin-based mass drug administration (MDA) is an effective control strategy for scabies in island settings, with a single round of MDA reducing population prevalence by around 90%. However, current two-dose regimens present a number of barriers to programmatic MDA implementation. We designed the Regimens of Ivermectin for Scabies Elimination (RISE) trial to investigate whether one-dose MDA may be as effective as two-dose MDA in controlling scabies in high-prevalence settings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>RISE is a cluster-randomised non-inferiority trial. The study will be conducted in 20 isolated villages in Western Province of Solomon Islands where population prevalence of scabies is approximately 20%. Villages will be randomly allocated to receive either one dose or two doses of ivermectin-based MDA in a 1:1 ratio. The primary objective of the study is to determine if ivermectin-based MDA with one dose is as effective as MDA with two doses in reducing the prevalence of scabies after 12 months. Secondary objectives include the effect of ivermectin-based MDA on impetigo prevalence after 12 and 24 months, the prevalence of scabies at 24 months after the intervention, the impact on presentation to health facilities with scabies and impetigo, and the safety of one-dose and two-dose MDA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>This trial has been approved by the ethics review committees of the Solomon Islands and the Royal Children's Hospital, Australia. Results will be disseminated in peer-reviewed publications and in meetings with the Solomon Islands Ministry of Health and Medical Services and participating communities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration details<\/jats:title><jats:p>Australian New Zealand Clinical Trials Registry: ACTRN12618001086257. Date registered: 28 June 2018.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2020-037305","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T07:10:37Z","timestamp":1598857837000},"page":"e037305","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study)"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5508-5430","authenticated-orcid":false,"given":"Susanna J","family":"Lake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie L","family":"Phelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Engelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Sokana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Titus","family":"Nasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dickson","family":"Boara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Gorae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibor","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anneke C","family":"Grobler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Millicent H","family":"Osti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-4743","authenticated-orcid":false,"given":"Michael","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot J","family":"Whitfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9038-5300","authenticated-orcid":false,"given":"Lucia","family":"Romani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kaldor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Steer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,8,30]]},"reference":[{"key":"2023071902300817000_10.8.e037305.1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"390","author":"Vos","year":"2017","journal-title":"The Lancet"},{"key":"2023071902300817000_10.8.e037305.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30483-8"},{"key":"2023071902300817000_10.8.e037305.3","first-page":"264","article-title":"Scabies: a clinical update","volume":"46","author":"Hardy","year":"2017","journal-title":"Aust Fam Physician"},{"key":"2023071902300817000_10.8.e037305.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.4211.405"},{"key":"2023071902300817000_10.8.e037305.5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S1473-3099(15)00132-2","article-title":"Prevalence of scabies and impetigo worldwide: a systematic review","volume":"15","author":"Romani","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2023071902300817000_10.8.e037305.6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004803","article-title":"The prevalence of scabies and impetigo in the Solomon Islands: a population-based survey","volume":"10","author":"Mason","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"2023071902300817000_10.8.e037305.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003452","article-title":"Scabies and impetigo prevalence and risk factors in Fiji: a national survey","volume":"9","author":"Romani","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2023071902300817000_10.8.e037305.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006668","article-title":"Scabies and risk of skin sores in remote Australian Aboriginal communities: a self-controlled case series study","volume":"12","author":"Aung","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2023071902300817000_10.8.e037305.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31136-5"},{"key":"2023071902300817000_10.8.e037305.10","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e3283511d27"},{"key":"2023071902300817000_10.8.e037305.11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/jpc.13851","article-title":"Scabies is strongly associated with acute rheumatic fever in a cohort study of Auckland children","volume":"54","author":"Thornley","year":"2018","journal-title":"J Paediatr Child Health"},{"key":"2023071902300817000_10.8.e037305.12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/INF.0000000000001013","article-title":"The importance of scabies coinfection in the treatment considerations for impetigo","volume":"35","author":"Tasani","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"2023071902300817000_10.8.e037305.13","unstructured":"eTG complete . Melbourne, Victoria: therapeutic guidelines LTD. Available: https:\/\/tgldcdp.tg.org.au.acs.hcn.com.au\/viewTopic?topicfile=insects-mites&guidelineName=Dermatology#toc_d1e110"},{"key":"2023071902300817000_10.8.e037305.14","unstructured":"WHO . Who model formulary for children. Geneva, Switzerland World Health Organisation; 2010."},{"key":"2023071902300817000_10.8.e037305.15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000495290","article-title":"A review of scabies: an infestation more than skin deep","volume":"235","author":"Chandler","year":"2019","journal-title":"Dermatology"},{"key":"2023071902300817000_10.8.e037305.16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/tropicalmed3030098","article-title":"Control strategies for scabies","volume":"3","author":"Engelman","year":"2018","journal-title":"Trop Med Infect Dis"},{"key":"2023071902300817000_10.8.e037305.17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1473-3099(18)30790-4","article-title":"Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial","volume":"19","author":"Romani","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2023071902300817000_10.8.e037305.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004246","article-title":"Long term control of scabies fifteen years after an intensive treatment programme","volume":"9","author":"Marks","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2023071902300817000_10.8.e037305.19","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92669-S"},{"key":"2023071902300817000_10.8.e037305.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(99)00087-X"},{"key":"2023071902300817000_10.8.e037305.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500987"},{"key":"2023071902300817000_10.8.e037305.22","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.16"},{"key":"2023071902300817000_10.8.e037305.23","doi-asserted-by":"crossref","first-page":"e1132","DOI":"10.1016\/S2214-109X(18)30397-8","article-title":"Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial","volume":"6","author":"Romani","year":"2018","journal-title":"Lancet Glob Health"},{"key":"2023071902300817000_10.8.e037305.24","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.pt.2019.08.002","article-title":"The challenge of developing a single-dose treatment for scabies","volume":"35","author":"Bernigaud","year":"2019","journal-title":"Trends Parasitol"},{"key":"2023071902300817000_10.8.e037305.25","unstructured":"World Health Organisation . Report of the tenth meeting of the who strategic and technical Advisory group for neglected tropical diseases, 2017."},{"key":"2023071902300817000_10.8.e037305.26","first-page":"CD012994","article-title":"Ivermectin and permethrin for treating scabies","volume":"4","author":"Rosumeck","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2023071902300817000_10.8.e037305.27","doi-asserted-by":"publisher","DOI":"10.1186\/1756-3305-5-299"},{"key":"2023071902300817000_10.8.e037305.28","doi-asserted-by":"crossref","first-page":"937","DOI":"10.4269\/ajtmh.18-0018","article-title":"Impact of ivermectin mass drug administration for lymphatic filariasis on scabies in eight villages in Kongwa district, Tanzania","volume":"99","author":"Martin","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2023071902300817000_10.8.e037305.29","unstructured":"Hodge N , Slatyer B , Skiller L . Solomon Islands health system review. Geneva, Switzerland: World Health Organisation, 2015."},{"key":"2023071902300817000_10.8.e037305.30","unstructured":"United Nations Development Programme . Human development indices and indicators: 2018 statistical update. Washington DC, USA; 2018."},{"key":"2023071902300817000_10.8.e037305.31","unstructured":"WHO . World health organisation model list of essential medicines, 21st list. Geneva World Health Organisation; 2019."},{"key":"2023071902300817000_10.8.e037305.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003507","article-title":"Growth, challenges, and solutions over 25 years of Mectizan and the impact on onchocerciasis control","volume":"9","author":"Lawrence","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2023071902300817000_10.8.e037305.33","first-page":"361","article-title":"Ivermectin dose assessment without weighing scales","volume":"71","author":"Alexander","year":"1993","journal-title":"Bull World Health Organ"},{"key":"2023071902300817000_10.8.e037305.34","first-page":"115","article-title":"Use of the Danish adoption register for the study of obesity and thinness","volume":"60","author":"Stunkard","year":"1983","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"key":"2023071902300817000_10.8.e037305.35","unstructured":"Australian medicines Handbook. Available: https:\/\/amhonline.amh.net.au.acs.hcn.com.au\/chapters\/dermatological-drugs\/scabicides-pediculicides\/permethrin"},{"key":"2023071902300817000_10.8.e037305.36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006996","article-title":"Exploration of a simplified clinical examination for scabies to support public health decision-making","volume":"12","author":"Marks","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2023071902300817000_10.8.e037305.37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006549","article-title":"Consensus criteria for the diagnosis of scabies: a Delphi study of international experts","volume":"12","author":"Engelman","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2023071902300817000_10.8.e037305.38","doi-asserted-by":"crossref","unstructured":"Engelman D , Yoshizumi J , Hay RJ , et al . The 2020 IACS consensus criteria for the diagnosis of scabies. Br J Dermatol 2020.doi:10.1111\/bjd.18943","DOI":"10.1111\/bjd.18943"},{"key":"2023071902300817000_10.8.e037305.39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007635","article-title":"The diagnosis of scabies by non-expert examiners: a study of diagnostic accuracy","volume":"13","author":"Osti","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2023071902300817000_10.8.e037305.40","unstructured":"Commonwealth of Australia . Australian public assessment report for ivermectin. Woden, ACT, Australia; 2013."},{"key":"2023071902300817000_10.8.e037305.41","doi-asserted-by":"publisher","DOI":"10.1177\/009127002401382731"},{"key":"2023071902300817000_10.8.e037305.42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000317"},{"key":"2023071902300817000_10.8.e037305.43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2004.01213.x"},{"key":"2023071902300817000_10.8.e037305.44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection","volume":"350","author":"Gardon","year":"1997","journal-title":"The Lancet"},{"key":"2023071902300817000_10.8.e037305.45","unstructured":"Ministry of Health and Medical Services . Solomon Islands essential medicines list. Honiara, Solomon Islands; 2017."},{"key":"2023071902300817000_10.8.e037305.46","article-title":"Interventions for treating scabies","volume":"2007","author":"Strong","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2023071902300817000_10.8.e037305.47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct0910329"},{"key":"2023071902300817000_10.8.e037305.48","first-page":"597","article-title":"Topical scabies therapy with permethrin is effective and well tolerated in infants younger than two months","volume":"17","author":"Hoffmann","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"key":"2023071902300817000_10.8.e037305.49","doi-asserted-by":"publisher","DOI":"10.1177\/0962280212439578"},{"key":"2023071902300817000_10.8.e037305.50","unstructured":"Provincial Profile of the 2009 Population & Housing Census: Western, Solomon Islands 2009."},{"key":"2023071902300817000_10.8.e037305.51","unstructured":"Hayes RJ , Moulton LH . Cluster randomised trials, second edition: CRC press, 2017: 424."},{"key":"2023071902300817000_10.8.e037305.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"2023071902300817000_10.8.e037305.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2023071902300817000_10.8.e037305.54","unstructured":"CONSORT . Consort transparent reporting of trials. Available: http:\/\/www.consort-statement.org\/"},{"key":"2023071902300817000_10.8.e037305.55","unstructured":"SPIRIT . Spirit statement. Available: https:\/\/www.spirit-statement.org\/"},{"key":"2023071902300817000_10.8.e037305.56","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2023071902300817000_10.8.e037305.57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004389"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-037305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T09:48:53Z","timestamp":1689760133000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-037305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":57,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,30]]},"published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1136\/bmjopen-2020-037305"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-037305","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}